Clinical Trials Browser

Phase 1 × Neutropenia × eflapegrastim × Clear all

NCT04187898 2024-09-19

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Phase 1 Completed

Breast Neoplasms, Neutropenia